Dr. Polly Niravath is board certified by the American Board of Internal Medicine in oncology and hematology. She is a breast oncologist for the Houston Methodist Cancer Center and spearheads the survivorship clinic. Her goal is to offer comprehensive care to patients, from diagnosis and treatment to long-term survivorship care. Her primary interests are breast cancer, symptom management, and aromatase inhibitor side effects. Dr. Niravath's research focuses on minimizing treatment-related side effects for breast cancer patients.
After completing her medical training at University of California at Irvine, Dr. Niravath completed both her residency and fellowship at Baylor College of Medicine. There, she received the Excellence in Teaching Award and also earned competitive grant funding for her clinical research from sources such as National Institutes of Health and National Comprehensive Cancer Network.
Dr. Niravath is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. She is fluent in Spanish and sees patients at Houston Methodist Hospital.